284 related articles for article (PubMed ID: 10690610)
21. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
22. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
Kubo S; Tanaka H; Shuto T; Takemura S; Yamamoto T; Kanazawa A; Uenishi T; Tanaka S; Hirohashi K; Nishiguchi S; Kinoshita H
Surg Today; 2005; 35(3):216-22. PubMed ID: 15772792
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
26. Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma.
Morinaga S; Tarao K; Yamamoto Y; Nakamura Y; Rino Y; Miyakawa K; Ohkawa S; Akaike M; Sugimasa Y; Takemiya S
J Gastroenterol Hepatol; 2007 Aug; 22(8):1249-55. PubMed ID: 17688665
[TBL] [Abstract][Full Text] [Related]
27. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
[TBL] [Abstract][Full Text] [Related]
28. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
29. The prognosis of patients with hepatocellular carcinoma of multicentric origin.
Okusaka T; Okada S; Nose H; Ishii H; Nakasuka H; Nakayama H; Nagahama H; Yoshimori M; Shimada K; Yamamoto J; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
Hepatogastroenterology; 1996; 43(10):919-25. PubMed ID: 8884314
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics of patients with hepatocellular carcinoma after hepatectomy: relationship with status of viral hepatitis.
Nanashima A; Abo T; Sumida Y; Takeshita H; Hidaka S; Furukawa K; Sawai T; Yasutake T; Masuda J; Morisaki T; Nagayasu T
J Surg Oncol; 2007 Nov; 96(6):487-92. PubMed ID: 17657729
[TBL] [Abstract][Full Text] [Related]
31. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia.
Wu CC; Cheng SB; Ho WM; Chen JT; Yeh DC; Liu TJ; P'eng FK
Surgery; 2004 Sep; 136(3):660-8. PubMed ID: 15349116
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.
Yamamoto J; Kosuge T; Saiura A; Sakamoto Y; Shimada K; Sano T; Takayama T; Sugawara Y; Yamaguchi T; Kokudo N; Makuuchi M
Jpn J Clin Oncol; 2007 Apr; 37(4):287-95. PubMed ID: 17553819
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
[TBL] [Abstract][Full Text] [Related]
34. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma.
Shirabe K; Takenaka K; Taketomi A; Kawahara N; Yamamoto K; Shimada M; Sugimachi K
Cancer; 1996 Mar; 77(6):1050-5. PubMed ID: 8635122
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
36. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.
Ng KK; Poon RT; Lo CM; Liu CL; Lam CM; Ng IO; Fan ST
Arch Surg; 2004 Feb; 139(2):193-200. PubMed ID: 14769580
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of primary hepatocellular carcinoma after hepatectomy--differences related to underlying hepatitis virus species.
Uchiyama K; Ueno M; Hama T; Kawai M; Tani M; Terasawa H; Ozawa S; Uemura R; Nakase T; Yamaue H
Hepatogastroenterology; 2005; 52(62):591-5. PubMed ID: 15816484
[TBL] [Abstract][Full Text] [Related]
38. Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis.
Chiappa A; Zbar A; Audisio RA; Paties C; Bertani E; Staudacher C
Hepatogastroenterology; 1999; 46(26):1145-50. PubMed ID: 10370682
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
[TBL] [Abstract][Full Text] [Related]
40. Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus.
Kubo S; Taukamoto T; Hirohashi K; Tanaka H; Shuto T; Takemura S; Kawai S; Wakasa K; Kinoshita H
World J Surg; 2003 Apr; 27(4):437-42. PubMed ID: 12658489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
